The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 8,820,562 | 465,465 | SH | SOLE | NONE | 465,465 | 0 | 0 | |
ABBVIE INC | COM | 00287Y109 | 12,236,313 | 90,821 | SH | SOLE | NONE | 90,821 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 3,033,532 | 15,971 | SH | SOLE | NONE | 15,971 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,377,834 | 102,940 | SH | SOLE | NONE | 102,940 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 18,098,282 | 46,438 | SH | SOLE | NONE | 46,438 | 0 | 0 | |
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 13,652,121 | 190,752 | SH | SOLE | NONE | 190,752 | 0 | 0 | |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,312,757 | 87,848 | SH | SOLE | NONE | 87,848 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 14,890,534 | 52,275 | SH | SOLE | NONE | 52,275 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 6,801,346 | 78,465 | SH | SOLE | NONE | 78,465 | 0 | 0 | |
BIOMEA FUSION INC | COM | 09077A106 | 558,671 | 25,452 | SH | SOLE | NONE | 25,452 | 0 | 0 | |
BIONTECH SE | SPONSORED ADS | 09075V102 | 4,005,066 | 37,108 | SH | SOLE | NONE | 37,108 | 0 | 0 | |
CHARLES RIV LABS INTL INC | COM | 159864107 | 1,451,776 | 6,905 | SH | SOLE | NONE | 6,905 | 0 | 0 | |
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,853,583 | 169,277 | SH | SOLE | NONE | 169,277 | 0 | 0 | |
GRITSTONE BIO INC | COM | 39868T105 | 185,582 | 95,170 | SH | SOLE | NONE | 95,170 | 0 | 0 | |
IMMUNOGEN INC | COM | 45253H101 | 10,253,165 | 543,358 | SH | SOLE | NONE | 543,358 | 0 | 0 | |
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 2,634,112 | 41,600 | SH | SOLE | NONE | 41,600 | 0 | 0 | |
IVERIC BIO INC | COM | 46583P102 | 9,632,832 | 244,861 | SH | SOLE | NONE | 244,861 | 0 | 0 | |
LILLY ELI & CO | COM | 532457108 | 7,594,193 | 16,193 | SH | SOLE | NONE | 16,193 | 0 | 0 | |
MERCK & CO INC | COM | 58933Y105 | 37,986,388 | 329,200 | SH | SOLE | NONE | 329,200 | 0 | 0 | |
MODERNA INC | COM | 60770K107 | 10,293,359 | 84,719 | SH | SOLE | NONE | 84,719 | 0 | 0 | |
MORPHOSYS AG | SPONSORED ADS | 617760202 | 324,938 | 43,499 | SH | SOLE | NONE | 43,499 | 0 | 0 | |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 4,243,500 | 45,000 | SH | SOLE | NONE | 45,000 | 0 | 0 | |
NOVO-NORDISK A S | ADR | 670100205 | 55,168,818 | 340,906 | SH | SOLE | NONE | 340,906 | 0 | 0 | |
PLIANT THERAPEUTICS INC | COM | 729139105 | 1,812,000 | 100,000 | SH | SOLE | NONE | 100,000 | 0 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,102,831 | 112,340 | SH | SOLE | NONE | 112,340 | 0 | 0 | |
ROIVANT SCIENCES LTD | SHS | G76279101 | 8,309,579 | 824,363 | SH | SOLE | NONE | 824,363 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 8,836,592 | 77,162 | SH | SOLE | NONE | 77,162 | 0 | 0 | |
SEAGEN INC | COM | 81181C104 | 9,849,141 | 51,175 | SH | SOLE | NONE | 51,175 | 0 | 0 | |
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 2,654,664 | 5,088 | SH | SOLE | NONE | 5,088 | 0 | 0 | |
TYRA BIOSCIENCES INC | COM | 90240B106 | 770,659 | 45,253 | SH | SOLE | NONE | 45,253 | 0 | 0 | |
VAXCYTE INC | COM | 92243G108 | 1,925,437 | 38,555 | SH | SOLE | NONE | 38,555 | 0 | 0 | |
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 6,444,880 | 18,314 | SH | SOLE | NONE | 18,314 | 0 | 0 | |
VIKING THERAPEUTICS INC | COM | 92686J106 | 6,217,832 | 383,580 | SH | SOLE | NONE | 383,580 | 0 | 0 | |
WATERS CORP | COM | 941848103 | 758,306 | 2,845 | SH | SOLE | NONE | 2,845 | 0 | 0 |